VBLT News and Press, Vascular Biogenics Ltd. From 08/30/21

Vinco Ventures (NASDAQ:BBIG) +65%. Aterian (NASDAQ:ATER) +52%. Support.com (NASDAQ:SPRT) +45%. Affirm Holdings (NASDAQ:AFRM) +40% as Amazon to integrate pay-over-time into its cart Globalstar (NYSE:GSAT) +36% on report iPhone 13 may use satellite connectivity Katapult...

U.S. FDA CMC clearance of VB-111 produced in Modiin, Israel facility an important milestone toward potential commercialization OVAL Phase 3 trial evaluating VB-111 in platinum resistant ovarian cancer has recruited nearly 80% of target enrollment; remains on track to complete ...

Vascular Biogenics Ltd (VBLT) Q2 2021 Earnings Conference Call August 16, 2021 08:30 AM ET Company Participants Dror Harats - Chief Executive Officer Amos Ron - Chief Financial Officer Conference Call Participants Etzer Darout - Guggenheim Securities Susan Chor - Oppenheimer & Co Ramakant...

Conference Call and Webcast at 8:30 a.m. EDT Today TEL AVIV, Israel, Aug. 16, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ) today announced financial results for the second quarter ended June 30, 2021, and provided a corporate update. “With $...

TEL AVIV, Israel, Aug. 05, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics ( Nasdaq: VBLT ) will release its second quarter financial results for the period ended June 30, 2021 on Monday, August 16 before market open. Professor Dror Harats, M.D, Chief Executive Officer and Amos Ron, Chief Fin...

TEL AVIV, Israel, July 22, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics ( Nasdaq: VBLT ) today announced the planned elevation of Marc Kozin as chairman of the company’s board of directors. Bennett Shapiro, M.D., has stepped down from his chairman role but remains on VBL...

TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger and Michael Rice to its Board of Directors, effective July 7, 2021. Professor Ruth Arnon has stepped down from her role as a member of VBL’s Board of ...

Gainers: Clearside Biomedical (CLSD) +30%, Eloxx Pharmaceuticals (ELOX) +15%, Fusion Pharmaceuticals (FUSN) +14%, Precipio (PRPO) +14%, Ocugen (OCGN) +11%.Losers: PDS Biotechnology (PDSB) -27%, Sage Therapeutics (SAGE) -16%, Neu...

Document Security Systems DSS -41% after secures $43.5M capital via equity raise.PDS Biotechnology PDSB -16% on proposing stock offering.Sage Therapeutics SAGE -12% after disappointing zuranolone secondary data in depression study.Vascular Biogenics VBLT -12...

koto_feja/E+ via Getty Images Vascular Biogenics (VBLT), operating as VBL Therapeutics has paused the recruitment of new patients in the U.S. for its ongoing OVAL Phase 3 study designed to investigate ofranergene obadenovec (VB-111), for the treatment of platinum-resistant ovarian cancer...